MedTrace Logo

Millipede AspiRation for Revascularization in Stroke (MARRS) Study

NCT05714501 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 235

Last updated 2026-07-10

Study results available
· View outcomes & findings →

Summary

The objectives of the study are to examine the performance and safety characteristics of the Millipede System when used for revascularization of patients with acute ischemic stroke due to Large Vessel Occlusions (LVOs) and to record associated clinical outcomes.

Conditions

  • Acute Ischemic Stroke

Interventions

DEVICE

Millipede System

Mechanical thrombectomy

Sponsors & Collaborators

  • Perfuze

    lead INDUSTRY

Principal Investigators

  • Raul Nogueira, MD · University of Pittsburgh Medical Center (UPMC), Pittsburgh, USA

  • Marc Ribo, MD · Vall D'Hebron Hospital, Barcelona, Spain

  • Ricardo Hanel, MD · Baptist Health Research Institute, Jacksonville, USA

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-09
Primary Completion
2025-03-08
Completion
2025-05-12
FDA Device
Yes

Countries

  • United States
  • France
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05714501 on ClinicalTrials.gov